Melittin complex nanometer granule for oral dosing and preparation method thereof

A technology of melittin and complex, applied in the field of medicine, can solve the problems of low encapsulation rate and no breakthrough progress, and achieve the effects of ensuring biological activity, overcoming bottlenecks and enhancing lipophilicity

Inactive Publication Date: 2009-04-15
SHENYANG PHARMA UNIVERSITY
View PDF0 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Pharmacists at home and abroad have used various methods to load water-soluble polypeptide macromolecules into nanomaterials to improve oral bioavailability, but there is still no breakthrough
Especially for water-soluble protein drugs, not only the preparation process requires severe conditions such as high temperature, high shear, and ultrasound, but also its hydrophobicity makes the encapsulation rate of water-soluble protein drugs low (<60%) (Yan P, HY Zhao, Hui X, et al.Effect of experimental parameters on the encap sulation of insulin2loadedpoly(lactide2co2glycolide) nanoparticles p prepared by a doubleemulsion method[J].J Chin Pharma Sci, 2002,11(1):38241.) Therefore, a suitable dosage form was developed , Improving the encapsulation rate of water-soluble protein peptide drugs, and then improving their bioavailability is a major problem for pharmaceutical workers to be overcome

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Melittin complex nanometer granule for oral dosing and preparation method thereof
  • Melittin complex nanometer granule for oral dosing and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Embodiment 1: the preparation of melittin-sodium lauryl sulfate complex

[0014] Take 4 mg of melittin and 2.4 mg of sodium lauryl sulfate and dissolve them in 1 ml of distilled water respectively, mix them, collect the resulting white precipitate, and freeze-dry for 12 hours to obtain a dry powder.

Embodiment 2

[0015] Embodiment 2: Preparation of melittin-sodium deoxycholate complex

[0016] Take 2.5 mg of melittin and 2 mg of sodium deoxycholate and dissolve them in 1 ml of distilled water, mix them, collect the resulting white precipitate, and freeze-dry for 12 hours to obtain a dry powder.

Embodiment 3

[0017] Embodiment 3: Preparation of melittin complex lactic acid-glycolic acid copolymer nanoparticles

[0018] Dissolve 140 mg of lactic acid-glycolic acid (75:25) with a molecular weight of 10500 in 4 ml of dimethyl sulfoxide solvent, and stir evenly. Take 12mg of melittin-sodium lauryl sulfate complex prepared in Example 1 and add it into the polymer solution, and stir until clarification. The above solution was poured into an aqueous solution containing 1% polyvinyl alcohol, and stirred at room temperature at 500 r / min for 4 hours to obtain a blue opalescent nanosuspension. SEM pictures see figure 1 . The measured encapsulation efficiency was 96%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
encapsulation rateaaaaaaaaaa
encapsulation rateaaaaaaaaaa
Login to view more

Abstract

The invention belongs to the technical field of medicines and discloses melittin complex nanoparticles for oral administration and a preparation method thereof. Water-soluble melittin and an amphiphilic substance are dissolved into a hydrosolvent A to form a hydrophobic protein ion pairing complex; the complex and a suitable polymer material are dissolved into a nonaqueous solvent B; an emulsion solvent diffusion method in a liquid phase is adopted to wrap the complex into the polymer material; and microparticles with the particle diameter between 10 and 1000nm are formed after the solvent is volatilized. The hydrosolvent A is distilled water, double distilled water, deionized water, physiological saline, or a phosphate buffer solution or an acetate buffer solution or a Tris buffer solution with the pH value of between 1 and 11; and the nonaqueous solvent B is a single or mixed solvent of alcohol, acetone, ethyl acetate, methylene dichloride, chloroform and dimethyl sulfoxide. The complex has high fat solubility, and the encapsulation rate of the nanoparticles is more than 90 percent. The preparation process is mild and can assure the biological activity of medicines. The preparation method is suitable to prepare oral administration preparations.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a melittin complex nanoparticle for oral administration and a preparation method thereof. Background technique [0002] With the development of biomedical technology, more and more protein and peptide drugs have been researched and developed and applied clinically. Bee Venom (bee venom, referred to as bee venom) is a kind of venom that is produced by the bee venom gland and stored in the poison sac. When the bee is stimulated, it is discharged from the sting needle of its tail. Peptide, histamine, phospholipase A 2 And hyaluronidase, etc., are biologically active substances containing a variety of natural peptides and enzymes, and have a long history of clinical application in my country. The main component of bee venom, melittin is a polypeptide composed of 26 amino acids, accounting for about 50% of the dry weight of bee venom. It has antibacterial, anti-inflammatory, anti-r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/17A61K9/14A61K47/32A61K47/34A61K47/36A61K47/38A61K47/42A61P19/02
Inventor 崔福德杨琳琳寸冬梅石凯
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products